Remove Biosimilars Remove Process Improvement Remove Vaccines
article thumbnail

The next industrial revolution in India will be driven by biotechnology

Express Pharma

He put forth the importance of Research and Development and regulatory systems, particularly for the deeper work needed in the biologics and biosimilar space. Reflecting on lessons from the last pandemic, he emphasised the importance of industrial capabilities, including manufacturing vaccines across multiple platforms.

Vaccines 105
article thumbnail

The next frontier: Global leadership in biopharma

Express Pharma

India has traced a journey of grit and glory to emerge as a major supplier of generic drugs and vaccines globally. IBER Report 2023 divulges, “The biopharma vaccines (non-COVID alone) market makes a significant daily contribution of approximately $38 million. Today, it is a key player in the global pharma landscape. billion monthly.”